Insulet stock jumps 6.03% and ends three-day losing streak

7 articles · Updated · MarketWatch · May 7

Shares closed at $160.40 on Thursday as the S&P 500 fell 0.38% and the Dow dropped 0.63% in a broadly weak session.
Insulet outperformed Eli Lilly, down 1.22%, Johnson & Johnson, down 0.94%, and DexCom, which rose 0.91%.
Trading volume reached 2.8 million shares, above its 50-day average of 1.1 million, though the stock remains 54.8% below its 52-week high of $354.88.

Is Insulet's stock a major bargain or a value trap after its recent earnings surge?

Insulet's stock is soaring, but can a serious product recall derail its impressive growth?